Anatara Lifesciences Ltd (ANR) Price & Analysis

Q: What is Anatara Lifesciences Ltd’s market cap?

Anatara Lifesciences Ltd’s market cap is AU$3.42M.

Q: When is Anatara Lifesciences Ltd’s upcoming earnings report date?

Anatara Lifesciences Ltd’s upcoming earnings report date is Mar 03, 2026 which is in 156 days.

Q: How were Anatara Lifesciences Ltd’s earnings last quarter?

Anatara Lifesciences Ltd released its earnings results on Aug 13, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.

Q: Is Anatara Lifesciences Ltd overvalued?

According to Wall Street analysts Anatara Lifesciences Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Anatara Lifesciences Ltd pay dividends?

Anatara Lifesciences Ltd does not currently pay dividends.

Q: What is Anatara Lifesciences Ltd’s EPS estimate?

Anatara Lifesciences Ltd’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Anatara Lifesciences Ltd have?

Anatara Lifesciences Ltd has 213,590,330 shares outstanding.

Q: What happened to Anatara Lifesciences Ltd’s price movement after its last earnings report?

Anatara Lifesciences Ltd reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Anatara Lifesciences Ltd?

Currently, no hedge funds are holding shares in AU:ANR

Compare

1 Followers

ANR Stock Chart & Stats

Day’s Range― - ―

52-Week Range<AU$0.01 - AU$0.07

Previous CloseN/A

Volume35.84K

Average Volume (3M)5.57M

Market Cap

AU$3.42M

Enterprise ValueAU$1.37M

Total Cash (Recent Filing)AU$1.10M

Total Debt (Recent Filing)AU$0.00

Price to Earnings (P/E)―

Beta-0.35

Next Earnings

Mar 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding213,590,330

10 Day Avg. Volume3,807,949

30 Day Avg. Volume5,571,797

Financial Highlights & Ratios

PEG Ratio0.09

Price to Book (P/B)4.60

Price to Sales (P/S)0.00

P/FCF Ratio-5.04

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Anatara Lifesciences Ltd News

Anatara Lifesciences Announces AGM and Director Nominations

Anatara Lifesciences Ltd ( ($AU:ANR) ) has provided an announcement. Anatara Lifesciences Ltd announced its Annual General Meeting...

13d ago

ANR

Anatara Lifesciences Addresses ASX Query Amid Market Activity

Anatara Lifesciences Ltd ( ($AU:ANR) ) just unveiled an update. Anatara Lifesciences Ltd has responded to a query...

23d ago

ANR

Anatara Lifesciences Announces Cessation of Securities

Anatara Lifesciences Ltd ( ($AU:ANR) ) has shared an update. Anatara Lifesciences Ltd has announced the cessation of...

1M ago

ANR

Anatara Lifesciences Reports Increased Loss Amidst Continued Operations

Anatara Lifesciences Ltd ( ($AU:ANR) ) has shared an update. Anatara Lifesciences Ltd reported a 35% increase in...

2M ago

ANR

Anatara Lifesciences Announces Quotation of New Securities on ASX

Anatara Lifesciences Ltd ( ($AU:ANR) ) has issued an announcement. Anatara Lifesciences Ltd has announced the quotation of...

2M ago

ANR

Anatara Lifesciences Converts Performance Rights to Shares

Anatara Lifesciences Ltd ( ($AU:ANR) ) just unveiled an update. Anatara Lifesciences Ltd has converted 206,612 performance rights...

2M ago

ANR

Anatara Lifesciences Advances GaRP-IBS Trial and Expands Patent Portfolio

Anatara Lifesciences Ltd ( ($AU:ANR) ) has provided an announcement. Anatara Lifesciences Ltd announced the completion of Stage...

2M ago

ANR

Anatara Lifesciences Secures R&D Tax Incentive to Propel Anti-Obesity Research

Anatara Lifesciences Ltd ( ($AU:ANR) ) has provided an announcement. Anatara Lifesciences Ltd has received $969,455 from the...

2M ago

ANR

Anatara Lifesciences Sees Change in Substantial Shareholder Interests

Anatara Lifesciences Ltd ( ($AU:ANR) ) just unveiled an announcement. Anatara Lifesciences Limited, a company listed on the...

3M ago

ANR

Anatara Lifesciences Secures Hong Kong Patent for GaRP Product

Anatara Lifesciences Ltd ( ($AU:ANR) ) has issued an announcement. Anatara Lifesciences Ltd has been granted a Hong...

4M ago

ANR

ANR FAQ

What was Anatara Lifesciences Ltd’s price range in the past 12 months?

Anatara Lifesciences Ltd lowest share price was <AU$0.01 and its highest was AU$0.07 in the past 12 months.

What is Anatara Lifesciences Ltd’s market cap?

Anatara Lifesciences Ltd’s market cap is AU$3.42M.

When is Anatara Lifesciences Ltd’s upcoming earnings report date?

Anatara Lifesciences Ltd’s upcoming earnings report date is Mar 03, 2026 which is in 156 days.

How were Anatara Lifesciences Ltd’s earnings last quarter?

Anatara Lifesciences Ltd released its earnings results on Aug 13, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.

Is Anatara Lifesciences Ltd overvalued?

According to Wall Street analysts Anatara Lifesciences Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Anatara Lifesciences Ltd pay dividends?

Anatara Lifesciences Ltd does not currently pay dividends.

What is Anatara Lifesciences Ltd’s EPS estimate?

Anatara Lifesciences Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Anatara Lifesciences Ltd have?

Anatara Lifesciences Ltd has 213,590,330 shares outstanding.

What happened to Anatara Lifesciences Ltd’s price movement after its last earnings report?

Anatara Lifesciences Ltd reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Anatara Lifesciences Ltd?

Currently, no hedge funds are holding shares in AU:ANR

Anatara Lifesciences Ltd Stock Smart Score

Underperform

Fundamentals

Return on Equity

-205.70%

Trailing 12-Months

Asset Growth

-31.29%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Anatara Lifesciences Ltd

Anatara Lifesciences Ltd (ANR) is an Australian biotechnology company that operates in the life sciences sector. The company is focused on developing products for human and animal health, particularly in the areas of gastrointestinal health. Anatara's core products include therapeutic and preventative solutions for conditions such as irritable bowel syndrome (IBS) in humans and gastrointestinal diseases in animals.